查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1829230

2025年全球注射给药装置市场报告

Injectable Drug Delivery Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，注射给药装置市场规模强劲成长，从2024年的495.9亿美元增加至2025年的543亿美元，复合年增长率达9.5%。预测期内的增长可归因于老年人口的快速增长、医疗机构数量的增加、医疗保健支出的增加、生技药品的增长以及自我给药意识的增强。

预计未来几年註射给药装置市场将强劲成长，到 2029 年将达到 738.5 亿美元，复合年增长率为 8.0%。预测期内的增长可归因于慢性病盛行率的上升、注射药物需求的增加、严重感染疾病的突然出现以及大量药品和疫苗处于多个临床试验阶段。预测期内的主要趋势包括专注于开发基于微针的给药系统、投资自行注射装置的研发、专注于製造可穿戴设备、专注于製造无针注射系统、扩大产品线以包括预填充式注射器、探索设备的数位化改进、专注于製造创新设备以及专注于製造创新型自动注射器。

注射给药装置是专门设计用于透过注射将药物直接注射到体内的医疗设备。此类装置可用于多种给药途径，包括静脉注射、皮下注射、皮内注射、腹腔注射和肌肉注射。

注射给药装置的主要类型包括传统注射器、预填充式注射器、自动注射器和笔式註射器。预填充式注射器配有固定针头，内含单剂量疫苗或其他药物。这类装置广泛应用于各种医疗保健领域，包括自体免疫疾病、荷尔蒙失调、肿瘤学、罕见疾病、疼痛管理和呼吸治疗。注射给药装置的终端用户多种多样，包括医院和诊所、家庭医疗保健机构、製药和生物技术公司以及实验室。

2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备行业产生了重大影响，尤其对用于诊断影像设备的进口零件、手术用不銹钢和一次性塑胶製品产生了重大影响。由于医院和诊所抵制涨价，製造商面临利润压力。监管挑战使情况更加复杂，因为由于关税而更换供应商通常需要重新认证医疗设备，导致市场进入延迟。为此，企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。

本研究报告是商业研究公司 (The Business Research Company) 新报告系列的一部分，该系列提供注射给药装置的市场统计数据，包括全球市场规模、各地区市场份额、各竞争对手的市场份额、详细的注射给药装置细分市场、市场趋势和商业机会，为您提供在註射给药装置行业取得成功所需的数据。本注射给药装置市场研究报告提供了完整的行业观点，并对当前和未来情况进行了深入分析。

未来五年8.0%的预测成长率，较我们先前对该市场的预测略有下降0.5%。下降主要源自于美国与其他国家之间关税的影响。这种影响可能会直接影响美国，导致来自英国和台湾等主要地区的自动注射器弹簧和针头安全护罩的供应链中断，从而可能减少患者的自主用药选择，并增加慢性病管理成本。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，这种影响可能会更加广泛。

由于人们对自动注射器的偏好日益增长，注射式给药装置市场正在蓬勃发展。这些医疗设备使患者能够在家中自行给药，包括无针注射器、自动注射器、笔式註射器和穿戴式註射器。一个显着的例子是BD Physioject，这是一款由Becton, Dickinson and Company生产的一次性自动注射器，专为慢性疾病患者的自行注射药物而设计。 Abbvie, Inc.、3M、Baxter、Gerresheimer AG和Pfizer Inc.等市场参与企业正积极参与自动注射器市场。自行注射的益处以及人们日益增强的自我给药意识，正在推动此类装置的需求不断增长，从而推动注射式给药装置市场的发展。

慢性病盛行率的上升进一步推动了注射给药装置市场的成长。注射给药装置提供了一种便捷可靠的长期用药方式，从而提高了患者的依从性并改善了健康状况。美国国家生物技术资讯中心 (NCBI) 预测，全球慢性病患者人数将大幅增加，到 2050 年将达到 1.4266 亿。慢性病盛行率的上升是注射给药装置市场的主要驱动力。

注射给药设备市场的製造商正专注于自动注射器，这是一种全自动、可自订且可重复使用的设备。自动注射器可让患者控制注射速度，最大限度地减少疼痛和不适。 UniLife Corporation 可重复使用的自动注射器 LISA 提供蓝牙低功耗连接、Wi-Fi 或 3G 连接以及注射前药物加热等功能。注射给药技术的技术进步和新产品的推出预计将推动市场大幅成长。

注射给药装置市场的主要企业正致力于开发自动注射器平台，以提高患者依从性、增强可用性并实现更安全、更有效的给药。自动注射器平台是一种旨在自动控制和给药特定剂量的医疗设备。例如，2022 年 5 月，美国医疗保健公司 Jabil Healthcare Inc. 推出了 Qfinity 自动注射器平台，这是一种可重复使用的给药装置，用于皮下 (SC) 自行注射各种注射药物。每个 Qfinity 自动注射器可注射超过 100 次，与一次性注射器相比，显着减少了医疗废弃物。这种耐用性促进了更永续的给药方式。它在药物容量和黏度方面具有灵活性，与 1 mL 和 2.25 mL预填充一次性盒相容，使其适用于多种药物，包括大容量、高黏度注射。

注射给药装置市场的主要企业包括 Becton、Dickinson and Company、Baxter International、Gerresheimer AG、Catalent, Inc.、SkyePharma PLC、Antares Pharma、Pfizer Inc、GE Healthcare、Owen Mumford、Catalent Pharma Solutions、Philips、WestCoceutical Services, Inc.、 LLC、Pendant Biosciences、Siemens、H&T Presspart、B Braun、Cop​​ernicus、Ypsomed AG、3M Company、Aptar、Congenica Ltd.、Julphar、Nemera、Stryker、Roche、Nektar Therapeutics、Eli Lilly、Merck & Co. Inc. Inc. Inc. Inc. Inc. Ltd.、GlaxoSmithKline、MediPrint Ophthalmics、Medtronic、诺华、Pharmasyntez、拜耳、Mylan NV、Aptalis Pharma, Inc.、赛诺菲、诺和诺德、Bilim Pharmaceuticals、巴特尔医疗设备、Caplin Steriles Limited、雅培林、艾尔建、Bilim Pharmaceuticals、巴特尔医疗设备、Caplin Steriles Limited、雅培林、艾尔盖、Bilim Pharmaceuticals、巴特尔医疗设备、Caplin Steriles Limited、雅培林、艾尔建、Terume、Trumn、Aaknillar. Corporation、Kedalion Therapeutics 和安进公司。

2024年，注射给药装置市场最大的地区是北美。西欧是全球注射给药装置市场的第二大地区。注射给药装置市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美、中东和非洲。

注射药物输送装置市场报告涵盖的国家：澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、义大利、加拿大、西班牙

注射给药装置市场涵盖传统注射器、无针注射器、自动注射器和笔式註射器的销售。此市场的价值为出厂价，即产品製造商或生产商向其他营业单位（包括下游製造商、批发商、经销商和零售商）或直接向最终客户销售的产品价值。该市场的产品价值还包括产品製造商提供的任何相关服务。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球注射药物输送装置：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球注射给药装置市场：成长率分析
  • 全球注射给药装置市场表现：规模与成长，2019-2024
  • 全球注射给药装置市场预测：规模与成长，2024-2029年，2034年
  • 全球注射给药装置：总目标市场（TAM）

第六章 市场细分

  • 全球注射给药装置市场类型、效能及预测（2019-2024、2024-2029、2034）
  • 注射器
  • 注射器
  • 泵浦
  • 全球注射给药装置市场应用、效能及预测（2019-2024、2024-2029、2034）
  • 自体免疫疾病
  • 荷尔蒙失调
  • 肿瘤学
  • 罕见疾病
  • 疼痛管理
  • 呼吸治疗
  • 其他的
  • 全球注射给药装置市场（依最终用户、绩效及预测），2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 家庭医疗保健环境
  • 製药和生物技术公司
  • 实验室
  • 其他的
  • 全球注射给药装置市场：注射器细分、类型、性能及预测（2019-2024、2024-2029、2034）
  • 传统注射器
  • 预填充式注射器
  • 安全注射器
  • 全球注射给药装置市场：注射器细分、类型、性能及预测（2019-2024、2024-2029、2034）
  • 自动注射器
  • 笔式註射器
  • 无针注射器
  • 全球注射给药装置市场：帮浦细分、类型、性能及预测（2019-2024 年、2024-2029 年、2034 年）
  • 胰岛素帮浦
  • 携带式输液泵
  • 植入式帮浦

第七章 区域和国家分析

  • 全球注射给药装置市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球注射给药装置市场：国家、绩效及预测（2019-2024、2024-2029、2034）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 注射给药装置市场：竞争格局
  • 注射给药装置市场：公司简介
    • Becton, Dickinson and Company
    • Baxter International
    • Gerresheimer AG
    • Catalent, Inc.
    • SkyePharma PLC

第31章：其他领先和创新企业

  • Antares Pharma
  • Pfizer Inc
  • GE Healthcare
  • Owen Mumford
  • Catalent Pharma Solutions
  • Philips
  • West Pharmaceutical Services, Inc.
  • Alkermes
  • Schott AG
  • UCB
  • AstraZeneca
  • Johnson & Johnson
  • NEARMEDIC PLUS LLC
  • Pendant Biosciences
  • Siemens

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第35章：市场潜力大的国家与策略

  • 2029年註射给药装置市场：提供新机会的国家
  • 2029年註射给药装置市场：细分市场带来新机会
  • 2029年註射给药装置市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r25717u

Injectable Drug Delivery Devices are medical devices specifically designed to deliver medications directly into the body via injections. These devices are utilized for multiple routes of drug administration, including intravenous, subcutaneous, intradermal, intraperitoneal, and intramuscular.

The primary types of injectable drug delivery devices include conventional injectables, pre-filled syringes, auto-injectors, and pen injectors. Pre-filled syringes come with a fixed needle and contain single-dose vaccines or other medications. These devices find applications in various medical areas such as autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, among others. Injectable drug delivery devices are utilized by a range of end-users, including hospitals and clinics, home healthcare settings, pharmaceutical and biotechnological companies, research laboratories, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The injectable drug delivery devices market research report is one of a series of new reports from The Business Research Company that provides injectable drug delivery devices market statistics, including injectable drug delivery devices industry global market size, regional shares, competitors with injectable drug delivery devices market share, detailed injectable drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the injectable drug delivery devices industry. This injectable drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The injectable drug delivery devices market size has grown strongly in recent years. It will grow from $49.59 billion in 2024 to $54.3 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to rapid growth in the elderly population, growth in the number of healthcare facilities, increased healthcare expenditure, growth in the biologics, and increasing awareness of self-administration.

The injectable drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $73.85 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing prevalence of chronic diseases, increasing demand for injectable drugs, sudden emergence of severe infections and large numbers of drugs and vaccines in several clinical trial stages. Major trends in the forecast period include focus on developing microneedle-based drug delivery systems, invest in the research and development of self-injectable devices, focus on manufacturing wearable devices, focus on the manufacturing of needle-free injection system, expanding its product line to prefilled syringes, consider improving the digital technology of their devices, focus on manufacturing innovative devices and focus on manufacturing innovative auto-injectors.

The forecast of 8.0% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for auto-injector springs and needle safety shields, sourced from key regions such as the UK and Taiwan, which could lead to reduced patient self-administration options and higher costs for chronic disease management.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The injectable drug delivery devices market is experiencing growth driven by the increasing preference for self-injection devices. These medical devices enable patients to self-administer medication in a home setting and include needle-free, auto, pen, and wearable injectors. Notable examples include BD Physioject, a disposable auto-injector by Becton, Dickinson, and Company, designed for self-injection of drugs in chronic diseases. Companies such as Abbvie, Inc., 3M, Baxter, Gerresheimer AG, and Pfizer Inc. are actively participating in the self-injections market. The advantages of self-injectables and growing awareness of self-administration contribute to the rising demand for such devices, propelling the injectable drug delivery devices market.

The growth of the injectable drug delivery devices market is further fueled by the increasing prevalence of chronic diseases. Injectable drug delivery devices offer a convenient and reliable method for administering medications over extended periods, enhancing patient adherence and improving health outcomes. The National Center for Biotechnology Information (NCBI) projects a significant increase in the global population with chronic diseases, reaching 142.66 million by 2050. This escalating prevalence is a key driver for the injectable drug delivery devices market.

Manufacturers in the injectable drug delivery devices market are placing emphasis on auto-injectors, fully automated, customizable, and reusable devices. Auto-injectors provide patients with control over injection speed, minimizing pain or discomfort. Unilife Corporation's LISA, a reusable auto-injector, offers features such as Bluetooth LE connectivity, Wi-Fi or 3G connectivity, and pre-injection drug warming. The technological advancements and new product launches in injectable drug delivery technology are expected to drive significant market growth.

Major companies in the injectable drug delivery devices market are focusing on developing autoinjector platforms to improve patient compliance, enhance usability, and ensure safer and more effective medication administration. An autoinjector platform is a medical device designed for the automatic and controlled delivery of a specific medication dosage. For example, in May 2022, Jabil Healthcare Inc., a US-based healthcare company, introduced the Qfinity autoinjector platform, a reusable drug delivery device intended for subcutaneous (SC) self-administration of various injectables. The Qfinity autoinjector can manage over 100 injections per device, significantly reducing medical waste compared to single-use devices. This durability promotes a more sustainable approach to drug delivery. It can accommodate 1 mL and 2.25 mL pre-filled disposable cassettes, providing flexibility in drug volume and viscosity, making it suitable for a wide array of medications, including larger-volume and higher-viscosity injectables.

Major companies operating in the injectable drug delivery devices market include Becton, Dickinson and Company, Baxter International, Gerresheimer AG, Catalent, Inc., SkyePharma PLC, Antares Pharma, Pfizer Inc, GE Healthcare, Owen Mumford, Catalent Pharma Solutions, Philips, West Pharmaceutical Services, Inc., Alkermes, Schott AG, UCB, AstraZeneca, Johnson & Johnson, NEARMEDIC PLUS LLC, Pendant Biosciences, Siemens, H&T Presspart, B Braun, Copernicus, Ypsomed AG, 3M Company, Aptar, Congenica Ltd., Julphar, Nemera, Stryker, Roche, Nektar Therapeutics, Eli Lilly, Merck & Co. Inc., Sandoz, Sorrel Medical, Teleflex Medical, Gilero, Teva Pharmaceutical Industries Ltd., GlaxoSmithKline, MediPrint Ophthalmics, Medtronic, Novartis, Pharmasyntez, Bayer, Mylan N.V, Aptalis Pharma, Inc., Sanofi, Novo Nordisk, Bilim Pharmaceuticals, Battelle Medical Devices, Caplin Steriles Limited, Abbot, Allergan, Boehringer Ingelheim, Hovione Technology, Jiangsu Delfu Medical Device Co, Ltd., Syqe Medical, Terumo Corporation, Kedalion Therapeutics, Amgen Inc.

North America was the largest region in the injectable drug delivery devices market in 2024. Western Europe was the second-largest region in the global injectable drug delivery devices market. The regions covered in the injectable drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the injectable drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The injectable drug delivery devices market consists of sales of conventional syringes, needle-free injectors, auto-injectors, and pen injectors. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Injectable Drug Delivery Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on injectable drug delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for injectable drug delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The injectable drug delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Syringes, Injectors And Pump
  • 2) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
  • 3) By End-user: Hospitals And Clinics, Home Healthcare Settings, Pharmaceutical And Biotechnological Companies, Research Laboratories, Other End Users
  • Subsegments:
  • 1) By Syringes: Conventional Syringes; Prefilled Syringes; Safety Syringes
  • 2) By Injectors: Autoinjectors; Pen Injectors; Needle-Free Injectors
  • 3) By Pumps: Insulin Pumps; Ambulatory Infusion Pumps; Implantable Pumps
  • Companies Mentioned: Becton, Dickinson and Company; Baxter International; Gerresheimer AG; Catalent, Inc.; SkyePharma PLC; Antares Pharma; Pfizer Inc; GE Healthcare; Owen Mumford; Catalent Pharma Solutions; Philips; West Pharmaceutical Services, Inc.; Alkermes; Schott AG; UCB; AstraZeneca; Johnson & Johnson; NEARMEDIC PLUS LLC; Pendant Biosciences; Siemens; H&T Presspart; B Braun; Copernicus; Ypsomed AG; 3M Company; Aptar; Congenica Ltd.; Julphar; Nemera; Stryker; Roche; Nektar Therapeutics; Eli Lilly; Merck & Co. Inc.; Sandoz; Sorrel Medical; Teleflex Medical; Gilero; Teva Pharmaceutical Industries Ltd.; GlaxoSmithKline; MediPrint Ophthalmics; Medtronic; Novartis; Pharmasyntez; Bayer; Mylan N.V; Aptalis Pharma, Inc.; Sanofi; Novo Nordisk; Bilim Pharmaceuticals; Battelle Medical Devices; Caplin Steriles Limited; Abbot; Allergan; Boehringer Ingelheim; Hovione Technology; Jiangsu Delfu Medical Device Co, Ltd.; Syqe Medical; Terumo Corporation; Kedalion Therapeutics; Amgen Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Injectable Drug Delivery Devices Market Characteristics

3. Injectable Drug Delivery Devices Market Trends And Strategies

4. Injectable Drug Delivery Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Injectable Drug Delivery Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Injectable Drug Delivery Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Injectable Drug Delivery Devices Market Growth Rate Analysis
  • 5.4. Global Injectable Drug Delivery Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Injectable Drug Delivery Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Injectable Drug Delivery Devices Total Addressable Market (TAM)

6. Injectable Drug Delivery Devices Market Segmentation

  • 6.1. Global Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Syringes
  • Injectors
  • Pump
  • 6.2. Global Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autoimmune Diseases
  • Hormonal Disorders
  • Oncology
  • Orphan Diseases
  • Pain Management
  • Respiratory Therapy
  • Other Applications
  • 6.3. Global Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Home Healthcare Settings
  • Pharmaceutical And Biotechnological Companies
  • Research Laboratories
  • Other End Users
  • 6.4. Global Injectable Drug Delivery Devices Market, Sub-Segmentation Of Syringes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conventional Syringes
  • Prefilled Syringes
  • Safety Syringes
  • 6.5. Global Injectable Drug Delivery Devices Market, Sub-Segmentation Of Injectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Autoinjectors
  • Pen Injectors
  • Needle-Free Injectors
  • 6.6. Global Injectable Drug Delivery Devices Market, Sub-Segmentation Of Pumps, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Insulin Pumps
  • Ambulatory Infusion Pumps
  • Implantable Pumps

7. Injectable Drug Delivery Devices Market Regional And Country Analysis

  • 7.1. Global Injectable Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Injectable Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Injectable Drug Delivery Devices Market

  • 8.1. Asia-Pacific Injectable Drug Delivery Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Injectable Drug Delivery Devices Market

  • 9.1. China Injectable Drug Delivery Devices Market Overview
  • 9.2. China Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Injectable Drug Delivery Devices Market

  • 10.1. India Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Injectable Drug Delivery Devices Market

  • 11.1. Japan Injectable Drug Delivery Devices Market Overview
  • 11.2. Japan Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Injectable Drug Delivery Devices Market

  • 12.1. Australia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Injectable Drug Delivery Devices Market

  • 13.1. Indonesia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Injectable Drug Delivery Devices Market

  • 14.1. South Korea Injectable Drug Delivery Devices Market Overview
  • 14.2. South Korea Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Injectable Drug Delivery Devices Market

  • 15.1. Western Europe Injectable Drug Delivery Devices Market Overview
  • 15.2. Western Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Injectable Drug Delivery Devices Market

  • 16.1. UK Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Injectable Drug Delivery Devices Market

  • 17.1. Germany Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Injectable Drug Delivery Devices Market

  • 18.1. France Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Injectable Drug Delivery Devices Market

  • 19.1. Italy Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Injectable Drug Delivery Devices Market

  • 20.1. Spain Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Injectable Drug Delivery Devices Market

  • 21.1. Eastern Europe Injectable Drug Delivery Devices Market Overview
  • 21.2. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Injectable Drug Delivery Devices Market

  • 22.1. Russia Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Injectable Drug Delivery Devices Market

  • 23.1. North America Injectable Drug Delivery Devices Market Overview
  • 23.2. North America Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Injectable Drug Delivery Devices Market

  • 24.1. USA Injectable Drug Delivery Devices Market Overview
  • 24.2. USA Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Injectable Drug Delivery Devices Market

  • 25.1. Canada Injectable Drug Delivery Devices Market Overview
  • 25.2. Canada Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Injectable Drug Delivery Devices Market

  • 26.1. South America Injectable Drug Delivery Devices Market Overview
  • 26.2. South America Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Injectable Drug Delivery Devices Market

  • 27.1. Brazil Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Injectable Drug Delivery Devices Market

  • 28.1. Middle East Injectable Drug Delivery Devices Market Overview
  • 28.2. Middle East Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Injectable Drug Delivery Devices Market

  • 29.1. Africa Injectable Drug Delivery Devices Market Overview
  • 29.2. Africa Injectable Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Injectable Drug Delivery Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Injectable Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Injectable Drug Delivery Devices Market Competitive Landscape And Company Profiles

  • 30.1. Injectable Drug Delivery Devices Market Competitive Landscape
  • 30.2. Injectable Drug Delivery Devices Market Company Profiles
    • 30.2.1. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Baxter International Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Gerresheimer AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Catalent, Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. SkyePharma PLC Overview, Products and Services, Strategy and Financial Analysis

31. Injectable Drug Delivery Devices Market Other Major And Innovative Companies

  • 31.1. Antares Pharma
  • 31.2. Pfizer Inc
  • 31.3. GE Healthcare
  • 31.4. Owen Mumford
  • 31.5. Catalent Pharma Solutions
  • 31.6. Philips
  • 31.7. West Pharmaceutical Services, Inc.
  • 31.8. Alkermes
  • 31.9. Schott AG
  • 31.10. UCB
  • 31.11. AstraZeneca
  • 31.12. Johnson & Johnson
  • 31.13. NEARMEDIC PLUS LLC
  • 31.14. Pendant Biosciences
  • 31.15. Siemens

32. Global Injectable Drug Delivery Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Injectable Drug Delivery Devices Market

34. Recent Developments In The Injectable Drug Delivery Devices Market

35. Injectable Drug Delivery Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Injectable Drug Delivery Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Injectable Drug Delivery Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Injectable Drug Delivery Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer